A Single Increasing Dose Study to Assess Safety and Tolerability of DX-2930 in Healthy Subjects

Clinical trial NCT01923207 · COMPLETED

Trial details

NCT number: NCT01923207
Sponsor: Shire
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hereditary Angioedema (HAE)

Start date: 2013-08-12
Primary completion: 2014-01-07
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.